ReviewAntibody therapeutics2020

Macrophage checkpoint blockade: results from initial clinical trials, binding analyses, and CD47-SIRPα structure-function.

AbdelAziz R Jalil et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.